OPTIMIZING THE DESIGN OF ANTISENSE THERAPEUTICS USING OLIGONUCLEOTIDE ARRAYS

OPTIMIZING THE DESIGN OF ANTISENSE THERAPEUTICS USING OLIGONUCLEOTIDE ARRAYS

Bibliographic Details
Main Authors:	Casegreen, S, Mir, K, Peters, N, Southern, E
Format:	Journal article
Published:	1994

Similar Items

Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays.
by: Southern, E, et al.
Published: (1997)

Selecting effective antisense reagents on combinatorial oligonucleotide arrays.
by: Milner, N, et al.
Published: (1997)

Determining the influence of structure on hybridization using oligonucleotide arrays.
by: Mir, K, et al.
Published: (1999)

Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies
by: Glenn A. Harris, et al.
Published: (2025-03-01)

Erratum: Determining the influence of structure on hybridization using oligonucleotide arrays (Nature Biotechnology)
by: Mir, K, et al.
Published: (1999)

Nonviral delivery systems for antisense oligonucleotide therapeutics
by: Si Huang, et al.
Published: (2022-09-01)

Determining the influence of structure on hybridization using oligonucleotide arrays (vol 17, pg 788, 1999)
by: Mir, K, et al.
Published: (2000)

Erratum: Determining the influence of structure on hybridization using oligonucleotide arrays (Nature Biotechnology (August 1999))
by: Mir, K, et al.
Published: (2000)

Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
by: Daisuke Ito, et al.
Published: (2024-12-01)

Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities
by: Jenny Lange, et al.
Published: (2022-06-01)

THERAPEUTIC ANTISENSE OLIGONUCLEOTIDES AGAINST CANCER: HURDLING TO THE CLINIC
by: Pedro Miguel Duarte Moreno, et al.
Published: (2014-10-01)

Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
by: Bao T. Le, et al.
Published: (2019-03-01)

Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
by: Maria Gagliardi, et al.
Published: (2022-01-01)

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
by: Sarah Bajan, et al.
Published: (2020-01-01)

Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases
by: Xue, K, et al.
Published: (2020)

Pharmacokinetics of antisense oligonucleotide drugs
by: M. R. Khaitov, et al.
Published: (2013-04-01)

Tissue pharmacokinetics of antisense oligonucleotides
by: Erica Bäckström, et al.
Published: (2024-03-01)

Antisense oligonucleotides in neurological disorders
by: Claudia D. Wurster, et al.
Published: (2018-05-01)

Optimizing tissue-specific antisense oligonucleotide-peptide conjugates.
by: Betts, C, et al.
Published: (2012)

Studies of oligonucleotide interactions by hybridisation to arrays: the influence of dangling ends on duplex yield.
by: Williams, J, et al.
Published: (1994)

Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection.
by: Yuanyuan Qiao, et al.
Published: (2023-01-01)

Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection
by: Yuanyuan Qiao, et al.
Published: (2023-01-01)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
by: Saumya Jani, et al.
Published: (2021-04-01)

Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics
by: Oleg V. Markov, et al.
Published: (2020-08-01)

Antisense oligonucleotide based therapeutics and its applications against bacterial infections
by: Nupur Angrish, et al.
Published: (2023-12-01)

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
by: Davide Di Fusco, et al.
Published: (2019-03-01)

Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement
by: Alexander Batista-Duharte, et al.
Published: (2020-02-01)

Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids.
by: Southern, E, et al.
Published: (1994)

Selective targeting of MYC by antisense oligonucleotides
by: Gill, Taylor Elizabeth
Published: (2018)

Towards understanding and applications of antisense oligonucleotides
by: Nguyen, Le Tuan Anh
Published: (2020)

Tofersen and other antisense oligonucleotides in ALS
by: Albert Ludolph, et al.
Published: (2025-01-01)

In-silico study of antisense oligonucleotide antibiotics
by: Erica S. Chen, et al.
Published: (2023-11-01)

History of Research on Antisense Oligonucleotide Analogs
by: Jack S. Cohen
Published: (2021-03-01)

Antisense Oligonucleotides: Concepts and Pharmaceutical Applications
by: Ariana Araya, et al.
Published: (2023-02-01)

Fluorescent base analogues in gapmers enable stealth labeling of antisense oligonucleotide therapeutics
by: Jesper R. Nilsson, et al.
Published: (2021-05-01)

Deep learning facilitates efficient optimization of antisense oligonucleotide drugs
by: Shenggeng Lin, et al.
Published: (2024-06-01)

Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
by: James S. Novak, et al.
Published: (2017-10-01)

Wrangling RNA: Antisense oligonucleotides for neurological disorders
by: Talbot, K, et al.
Published: (2019)

The Use of Antisense Oligonucleotides in Evaluating Survivin as a Therapeutic Target for Radiation Sensitization in Lung Cancer
by: Shinohara Eric T., et al.
Published: (2004-01-01)

Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference
by: Olga Golounina, et al.
Published: (2025-01-01)